欧蛋白介导的自会产生抗疟疾药物耐药性
Prakriti Sharma1, Neil Roy Chaudhary1, Sonia Devi1,2
1Division of Cell Biology and Immunology, Biomedical Parasitology and Translational-Immunology Lab, CSIR Institute of Microbial Technology (IMTECH), Chandigarh, India.
Frontiers in microbiology
|September 4, 2024
概括
欧蛋白诱导Plasmodium falciparum的自,这是寄生虫在药物压力下生存的关键机制. 这一发现为开发抗疟疾药物和打击耐药性提供了新的途径.
科学领域:
- 疟疾学 疟疾学
- 寄生虫学的寄生虫学
- 细胞生物学 细胞生物学
背景情况:
- 杆菌 (Plasmodium falciparum) 的抗疟疾药物耐药性是全球主要的健康威胁.
- 寄生虫利用诸如自的机制来生存药物压力.
- 缺乏有效的疫苗加剧了疟疾控制的挑战.
研究的目的:
- 为了研究自在P. falciparum在oleuropein诱导的压力下生存的作用.
- 探索生存/自轴作为抗疟疾药物开发的目标.
- 为了利用一个人性化的小鼠模型进行临床前的研究,对oleuropein诱导的自.
主要方法:
- 在P.falciparum中使用oleuropein诱导自.
- 在药物压力下对寄生虫生存机制的分析.
- 使用P. falciparum感染的人性化小鼠模型进行的临床前研究.
主要成果:
- 欧蛋白有效地诱导了P. falciparum的自.
- 自在对抗药物压力的寄生虫生存中起着至关重要的作用.
- 这种人性化的小鼠模型显示了oleuropein诱导的自.
结论:
- 自是P. falciparum的一个关键生存机制,特别是在药物压力下.
- 准生存/自轴是一个有希望的战略,以克服抗疟疾药物耐药性.
- 在人性化的小鼠模型中,欧蛋白诱导的自为未来研究提供了宝贵的工具.
相关概念视频
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Proteasome
818
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
818
Carrier-Mediated Transport
316
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
316


